Clinical Trial Update: Development and Validation of EHP-30 (Hong Kong Chinese Version) for Patients With Endometriosis and Adenomyosis

View source ↗

Summary

This update describes the development and validation of the Hong Kong Chinese version of the EHP-30, a patient-reported outcome measure for women with endometri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenomyosis
• Endometriosis

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Endometriosis, Adenomyosis | Status: COMPLETED